Bile duct cancer
MONDO:0003059A malignant neoplasm involving the bile duct
Also known as: bile duct tumor, bile duct tumour, bile duct cancer, cancer of bile duct, malignant bile duct neoplasm, malignant neoplasm of bile duct, malignant neoplasm of the extrahepatic bile duct
3354 clinical trials for this condition and its sub-types, 34 tagged with Bile duct cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bile duct cancer
-
Bile duct carcinoma 20 trials · 454 incl. sub-types
4 sub-types
- Extrahepatic bile duct carcinoma 51 trials · 432 incl. sub-types Sub-types →
- Bile duct adenocarcinoma 17 trials · 419 incl. sub-types Sub-types →
- Bile duct carcinoma in situ 0 trials Sub-types →
- Squamous cell bile duct carcinoma 0 trials Sub-types →
-
Malignant tumor of extrahepatic bile duct 1 trial · 434 incl. sub-types
3 sub-types
- Extrahepatic bile duct carcinoma 51 trials · 432 incl. sub-types Sub-types →
- Ampulla of vater cancer 5 trials · 69 incl. sub-types Sub-types →
- Extrahepatic bile duct sarcoma 0 trials Sub-types →
-
Intrahepatic bile duct cancer 6 trials · 179 incl. sub-types
2 sub-types
- Intrahepatic cholangiocarcinoma 154 trials · 176 incl. sub-types Sub-types →
- Intrahepatic bile duct adenosquamous carcinoma 0 trials
-
Bile duct sarcoma 0 trials
1 sub-type
Most studied deeper sub-types
-
New drug combo tested for tough bile duct cancers
Disease control Stopped earlyThis study tested a new drug called LSTA1 added to standard treatment for people with advanced bile duct or gallbladder cancer. The goal was to see if the combination is safe and works better than standard treatment alone. The trial was stopped early, and results are not yet avai…
Phase 2 • Sponsor: Lisata Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental virus therapy VAXINIA tested in advanced cancer patients
Disease control Stopped earlyThis early-stage study tested a new treatment called VAXINIA (CF33-hNIS), a virus designed to attack cancer cells, in 66 adults with advanced solid tumors that had spread. The treatment was given alone or with the immunotherapy drug pembrolizumab, either as a shot into the tumor …
Phase 1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC